Literature DB >> 3567463

Cellular electrophysiological effects of D- and DL-sotalol in guinea-pig sinoatrial node, atrium and ventricle and human atrium: differential tissue sensitivity.

T J Campbell.   

Abstract

The effects of racemic DL-sotalol and D-sotalol on guinea-pig sino-atrial node, atrium and ventricle and on human atrium were studied using standard microelectrode techniques. Both compounds increased spontaneous sinus node cycle length largely by prolonging the repolarization phase of the action potentials. This effect was attributed to blockade of outward potassium current. Ventricular action potential duration was similarly prolonged by DL-sotalol at concentrations of 5-50 microM. DL-Sotalol 1-50 microM had no effect on guinea-pig atrial action potential duration and D-sotalol produced minor prolongation only at the highest concentration (50 microM). Human atrial action potentials were, however, significantly prolonged by both DL- and D-sotalol 10 microM. This indicates differential sensitivities to sotalol for human and guinea-pig atrium and explains the ability of sotalol to prolong atrial monophasic action potential duration in clinical studies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3567463      PMCID: PMC1917192          DOI: 10.1111/j.1476-5381.1987.tb11210.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists.

Authors:  P M Lish; J H Weikel; K W Dungan
Journal:  J Pharmacol Exp Ther       Date:  1965-08       Impact factor: 4.030

2.  Sotalol intoxication with prolonged Q-T interval and severe tachyarrhythmias.

Authors:  E Elonen; P J Neuvonen; L Tarssanen; R Kala
Journal:  Br Med J       Date:  1979-05-05

3.  Electrophysiologial and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue.

Authors:  H C Strauss; J T Bigger; B F Hoffman
Journal:  Circ Res       Date:  1970-06       Impact factor: 17.367

4.  Sotalol and prolonged Q-Tc interval.

Authors:  P J Neuvonen; E Elonen; A Tanskanen; J Tuomilehto
Journal:  Lancet       Date:  1981-08-22       Impact factor: 79.321

5.  Sotalol-induced delayed ventricular repolarization in man.

Authors:  N Edvardsson; I Hirsch; H Emanuelsson; J Pontén; S B Olsson
Journal:  Eur Heart J       Date:  1980-10       Impact factor: 29.983

6.  Prolongation of the human cardiac monophasic action potential by sotalol.

Authors:  D S Echt; L E Berte; W T Clusin; R G Samuelsson; D C Harrison; J W Mason
Journal:  Am J Cardiol       Date:  1982-11       Impact factor: 2.778

7.  Electrophysiological effects of sotalol--just another beta blocker?

Authors:  A W Nathan; K J Hellestrand; R S Bexton; D E Ward; R A Spurrell; A J Camm
Journal:  Br Heart J       Date:  1982-06

8.  Acute prolongation of myocardial refractoriness by sotalol.

Authors:  D H Bennett
Journal:  Br Heart J       Date:  1982-06

9.  A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

10.  Effect of sotalol on human atrial action potential duration and refractoriness: cycle length dependency of class III activity.

Authors:  R P Hayward; P Taggart
Journal:  Cardiovasc Res       Date:  1986-02       Impact factor: 10.787

View more
  9 in total

1.  Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations.

Authors:  Serge Sicouri; Marc Pourrier; John K Gibson; Joseph J Lynch; Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2011-10-20       Impact factor: 6.343

2.  Cardiac electrophysiological actions of captopril: lack of direct antiarrhythmic effects.

Authors:  P D Hemsworth; R T Pallandi; T J Campbell
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

3.  Blockade of delayed rectifier K+ currents in neuroblastoma x glioma hybrid (NG 108-15) cells by clofilium, a class III antidysrhythmic agent.

Authors:  H L Reeve; C Peers
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

4.  Depression of maximum rate of depolarization of guinea-pig ventricular action potentials by metabolites of encainide.

Authors:  P D Hemsworth; T J Campbell
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

5.  Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation.

Authors:  Akira Takahara; Atsushi Sugiyama; Keitaro Hashimoto
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

6.  Negative chronotropic effect of a novel class III antiarrhythmic drug, UK-68,798, devoid of beta-blocking action on isolated guinea-pig atria.

Authors:  T Yang; P M Tande; H Refsum
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

7.  (+)-sotalol causes significant occupation of beta-adrenoceptors at concentrations that prolong cardiac repolarization.

Authors:  J Reid; G Duker; O Almgren; V Nerme
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

Review 8.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

9.  Class III antiarrhythmic drugs (amiodarone, bretylium and sotalol) on action potentials and membrane currents in rabbit sino-atrial node preparations.

Authors:  H Satoh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-12       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.